Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count.
Tani S, Matsumoto M, Anazawa T, Kawamata H, Furuya S, Takahashi H, Iida K, Washio T, Kumabe N, Kobori M, Nagao K, Hirayama A. Tani S, et al. Among authors: anazawa t. Heart Vessels. 2012 Mar;27(2):143-50. doi: 10.1007/s00380-011-0130-8. Epub 2011 Mar 18. Heart Vessels. 2012. PMID: 21416115
Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound.
Tani S, Watanabe I, Anazawa T, Kawamata H, Tachibana E, Furukawa K, Sato Y, Nagao K, Kanmatsuse K, Kushiro T; Surugadai Atherosclerosis Regression Investigators. Tani S, et al. Among authors: anazawa t. Am J Cardiol. 2005 Oct 15;96(8):1089-94. doi: 10.1016/j.amjcard.2005.05.069. Epub 2005 Aug 29. Am J Cardiol. 2005. PMID: 16214443 Clinical Trial.
Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: implication of acute coronary events.
Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Fuji T, Takahashi H, Iida K, Matsumoto M, Kumabe T, Sato Y, Hirayama A. Tani S, et al. Among authors: anazawa t. Int J Cardiol. 2009 Jun 26;135(2):202-6. doi: 10.1016/j.ijcard.2008.03.071. Epub 2008 Jul 9. Int J Cardiol. 2009. PMID: 18614250
Coronary plaque regression and lifestyle modification in patients treated with pravastatin. - Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol -.
Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, Iida K, Matsumoto M, Washio T, Kumabe N, Hirayama A. Tani S, et al. Among authors: anazawa t. Circ J. 2010 May;74(5):954-61. doi: 10.1253/circj.cj-09-0705. Epub 2010 Mar 17. Circ J. 2010. PMID: 20234098 Free article. Clinical Trial.
182 results